Lee's Pharmaceutical Holdings (HKSE:00950) Short-Term Debt : HK$161 Mil (As of Jun. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Lee's Pharmaceutical Holdings Short-Term Debt?

Lee's Pharmaceutical Holdings's Short-Term Debt for the quarter that ended in Jun. 2024 was HK$161 Mil.

Lee's Pharmaceutical Holdings's quarterly Short-Term Debt increased from Jun. 2023 (HK$109 Mil) to Dec. 2023 (HK$122 Mil) and increased from Dec. 2023 (HK$122 Mil) to Jun. 2024 (HK$161 Mil).

Lee's Pharmaceutical Holdings's annual Short-Term Debt declined from Dec. 2021 (HK$163 Mil) to Dec. 2022 (HK$77 Mil) but then increased from Dec. 2022 (HK$77 Mil) to Dec. 2023 (HK$122 Mil).

Lee's Pharmaceutical Holdings Short-Term Debt Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings Short-Term Debt Chart

Lee's Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

144.83

141.38

162.54

76.73

122.12

Lee's Pharmaceutical Holdings Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Short-Term Debt	Get a 7-Day Free Trial															136.41	76.73	108.88	122.12	160.84

Lee's Pharmaceutical Holdings Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Lee's Pharmaceutical Holdings Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Lee's Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (HKSE:00950) » Definitions » Short-Term Debt

Traded in Other Exchanges

LPCUF:USA L1PA:Germany

Address

Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG

Website

https://www.leespharm.com

Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Executives

Leelalertsuphakun Wanee	2101 Beneficial owner
Huang Zuie-chin	2201 Interest of corporation controlled by you
Lue Shuk Ping Vicky	2202 Interest of your spouse
Li Xiaoyi	2101 Beneficial owner
Lee Siu Fong	2101 Beneficial owner
Ubs Group Ag	2201 Interest of corporation controlled by you
Panacea Venture Healthcare Fund Ii, L.p.	2101 Beneficial owner
Panacea Innovation Limited	2201 Interest of corporation controlled by you
Guang Dong Min Ying Tou Zi Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Qualister Sa	2101 Beneficial owner
Paponi Claudia	2202 Interest of your spouse
Cavazza Paolo	2201 Interest of corporation controlled by you
Apta Finance Sa	2201 Interest of corporation controlled by you
Fmr Llc	2201 Interest of corporation controlled by you
Gsr Capital Joy Corporation	2101 Beneficial owner

Lee's Pharmaceutical Holdings Headlines

No Headlines